申请人:BRISTOL-MYERS SQUIBB COMPANY
公开号:US20150266856A1
公开(公告)日:2015-09-24
Described are RORy modulators of the formula (I), and N-oxides thereof, and pharmaceutically acceptable salts thereof, and solvates and hydrates thereof, wherein R
1
, R
2
, R
3
, R
4
, R
5
, R
6
, R
a
, x, y, L, G, Z, the bond denoted by “q”, the ring system denoted by “A” and the ring system denoted by “B” are defined herein. Also provided are pharmaceutical compositions comprising the same. Such compounds and compositions are useful in methods for modulating RORy activity in a cell and methods for treating a subject suffering from a disease or disorder in which the subject would therapeutically benefit from modulation of RORy activity, for example, autoimmune and/or inflammatory disorders.
本文描述了公式(I)的RORy调节剂及其N-氧化物、药学上可接受的盐、溶剂和水合物,其中R1、R2、R3、R4、R5、R6、Ra、x、y、L、G、Z、“q”表示的键、表示的环系统“A”和表示的环系统“B”在此定义。还提供了包含这些化合物的制药组合物。这些化合物和组合物在调节细胞中的RORy活性的方法和治疗患有疾病或障碍的受试者中是有用的,其中该受试者在调节RORy活性方面具有治疗益处,例如自身免疫和/或炎症性疾病。